Representative before the EPO

Technology company logo thumb
no operation time available
3 offices
Technology Company

We have observed 10 EP applications Alison Lesley Lee has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after November 15, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12723206

BCMA (CD269/TNFRSF17) -BINDING PROTEINS

IPC classification:
A61K 47/48, C07K 16/28
Applicant:
Glaxo Group Limited
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP13750350

ANTI LRP6 ANTIBODIES

IPC classification:
C07K 16/28
Applicant:
Glaxo Group Limited
Agent:
Alison Lesley Lee, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14703286

TNF-ALPHA ANTIGEN-BINDING PROTEINS

IPC classification:
A61K 39/395, C07K 16/24
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Alison Lesley Lee, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP15197750

LIQUID FORMULATION COMPRISING ADALIMUMAB AND AN ACETATE BUFFER

IPC classification:
C07K 16/24
Applicant:
Glaxo Group Limited
Agent:
Alison Lesley Lee, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP15724070

ANTIBODY FORMULATION

IPC classification:
A61K 39/395, C07K 16/28
Agent:
Alison Lesley Lee, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP16183212

CYTOTOXIC ANTI-LAG-3 MONOCLONAL ANTIBODY AND ITS USE IN THE TREATMENT OR PREVENTION OF ORGAN TRANSPLANT REJECTION AND AUTOIMMUNE DISEASE

IPC classification:
C12N 5/0783, C07K 16/28, A61K 39/00
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Alison Lesley Lee, GlaxoSmithKline
Status:
Request for examination was made
EP16770261

DOSING REGIMEN OF COMBINATION OF ANTI-CD20 AND ANTI-BLYS ANTIBODIES

IPC classification:
A61P 37/00, C07K 16/28
Agent:
Alison Lesley Lee, GlaxoSmithKline
Status:
Request for examination was made
EP16791700

PROGNOSTIC METHOD

IPC classification:
A61K 39/395, G01N 33/574
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Alison Lesley Lee, GlaxoSmithKline
Status:
Request for examination was made
EP18163940

ANTIGEN BINDING PROTEINS TO ONCOSTATIN M (OSM)

IPC classification:
C07K 16/24
Applicant:
Glaxo Group Limited
Agent:
Alison Lesley Lee, GlaxoSmithKline
Status:
Request for examination was made
EP16810068

COMBINATION TREATMENTS AND USES AND METHODS THEREOF

IPC classification:
C07K 16/28
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Alison Lesley Lee, GlaxoSmithKline
Status:
Request for examination was made

Please Sign in to use this feature